“We think this is good news.

I have already said that the Russian Federation really has a large and successful experience in the development of vaccines. We desperately need to expand our portfolio of vaccines, so I consider this (the beginning of the examination) a very long-awaited event, "Kluge quotes TASS.

Earlier it became known that the EMA began a procedure for the consistent examination of the registration dossier of the Russian vaccine against coronavirus Sputnik V.

It was also reported that Slovakia became the second country in the EU after Hungary to allow the use of Sputnik V.